Skip to main content
Premium Trial:

Request an Annual Quote

Lucence: Chao Xie

Singapore-based precision oncology company Lucence has appointed Chao Xie as chief data scientist to develop advanced analytics of ultrasensitive liquid biopsy diagnostics for cancer. Xie previously served as head of data science at AirAsia. He won a US Defense Threat Reduction Agency $1M global competition in 2013 for designing an algorithm to rapidly and accurately identify dangerous viruses and bacteria in gene sequencing data.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.